Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
D000818:Animals; D004298:Dopamine / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D007267:Injections; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009714:Nucleus Accumbens / Q000378:metabolism; D017294:Ondansetron; D010446:Peptide Fragments; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology; D013681:Tegmentum Mesencephali
D007093:Imidazoles; D010446:Peptide Fragments; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D012701:Serotonin; D013373:Substance P; D017294:Ondansetron; C032720:substance P (5-11), pGlu(5)-MePhe(8)-MeGly(9)-; D011761:Pyrrolidonecarboxylic Acid; D004298:Dopamine